B
Braidwell Portfolio holdings
AUM
$2.92B
This Quarter Return
+4.56%
1 Year Return
-4.59%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$2.72B
AUM Growth
+$2.72B
(-14%)
Cap. Flow
-$511M
Cap. Flow
% of AUM
-18.76%
Top 10 Holdings %
Top 10 Hldgs %
40.29%
Holding
93
New
5
Increased
13
Reduced
23
Closed
19
Top Buys
| 1 |
argenx
ARGX
|
$58.3M |
| 2 |
Penumbra
PEN
|
$32.1M |
| 3 |
Tourmaline Bio
TRML
|
$23.7M |
| 4 |
Inspire Medical Systems
INSP
|
$17.2M |
| 5 |
Krystal Biotech
KRYS
|
$14.7M |
Top Sells
| 1 |
Boston Scientific
BSX
|
$61.5M |
| 2 |
Natera
NTRA
|
$44.8M |
| 3 |
Merus
MRUS
|
$42.1M |
| 4 |
Glaukos
GKOS
|
$36M |
| 5 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
$34.9M |
Sector Composition
| 1 | Healthcare | 48.6% |
| 2 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Neurocrine Biosciences
NBIX
$13.8B
| $94.2M | 3.46% | 715,209 -252,815 | -26% | -$33.3M |
|
2
Vaxcyte
PCVX
$4B
| $81M | 2.98% | 1,289,965 -329,588 | -20% | -$20.7M |
|
3
Xenon Pharmaceuticals
XENE
$2.98B
| $75.9M | 2.79% | 1,647,311 -456,085 | -22% | -$21M |
|
4
Day One Biopharmaceuticals
DAWN
$769M
| $61.5M | 2.26% | 4,215,573 +500,000 | +13% | +$7.3M |
|
5
iRhythm Technologies
IRTC
$5.46B
| $60.8M | 2.23% | 568,157 | – | – |
|
|
6
argenx
ARGX
$43.6B
| $58.3M | 2.14% | +153,204 | New | +$58.3M |
|
|
7
Penumbra
PEN
$10.6B
| $56M | 2.06% | 222,792 +127,477 | +134% | +$32.1M |
|
8
Keros Therapeutics
KROS
$618M
| $44.5M | 1.63% | 1,118,961 -238,348 | -18% | -$9.48M |
|
|
FNA
9
DELISTED
Paragon 28, Inc.
FNA
| $41.8M | 1.53% | 3,361,824 | – | – |
|
10
Immunocore
IMCR
$1.62B
| $41.8M | 1.53% | 611,365 -295,608 | -33% | -$20.2M |
|
11
Thermo Fisher Scientific
TMO
$186B
| $40.2M | 1.48% | 75,749 | – | – |
|
12
Align Technology
ALGN
$10.3B
| $40.1M | 1.47% | 146,313 +21,100 | +17% | +$5.78M |
|
|
NVRO
13
DELISTED
NEVRO CORP.
NVRO
| $38.2M | 1.4% | 1,776,368 | – | – |
|
|
14
Inspire Medical Systems
INSP
$2.77B
| $37.6M | 1.38% | 184,658 +84,358 | +84% | +$17.2M |
|
15
OrthoPediatrics
KIDS
$536M
| $36M | 1.32% | 1,107,770 +50,000 | +5% | +$1.63M |
|
16
BioCryst Pharmaceuticals
BCRX
$1.74B
| $34.3M | 1.26% | 5,718,477 +355,497 | +7% | +$2.13M |
|
17
Legend Biotech
LEGN
$6.41B
| $33.9M | 1.24% | 562,600 -316,964 | -36% | -$19.1M |
|
18
Maravai LifeSciences
MRVI
$350M
| $33M | 1.21% | 5,040,635 +1,065,778 | +27% | +$6.98M |
|
19
Lantheus
LNTH
$3.73B
| $30.7M | 1.13% | 495,100 +206,800 | +72% | +$12.8M |
|
20
Alector
ALEC
$238M
| $26.5M | 0.97% | 3,324,308 -749,812 | -18% | -$5.98M |
|
|
21
Krystal Biotech
KRYS
$4.27B
| $24.3M | 0.89% | 196,200 +118,703 | +153% | +$14.7M |
|
|
22
Tourmaline Bio
TRML
$601M
| $23.7M | 0.87% | +906,820 | New | +$23.7M |
|
23
Guardant Health
GH
$8.41B
| $20.5M | 0.75% | 758,928 +69,928 | +10% | +$1.89M |
|
|
24
Glaukos
GKOS
$5.5B
| $19.3M | 0.71% | 242,760 -453,032 | -65% | -$36M |
|
25
Apogee Therapeutics
APGE
$2.17B
| $19M | 0.7% | 681,101 +189,988 | +39% | +$5.31M |
|